AG

Artal Group Portfolio holdings

AUM $930M
This Quarter Return
+5.69%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$3.88B
AUM Growth
+$3.88B
Cap. Flow
+$10.3M
Cap. Flow %
0.27%
Top 10 Hldgs %
90.38%
Holding
98
New
16
Increased
18
Reduced
14
Closed
4

Top Buys

1
XLRN
Acceleron Pharma Inc.
XLRN
$15.9M
2
MET icon
MetLife
MET
$10.6M
3
IONS icon
Ionis Pharmaceuticals
IONS
$10.1M
4
TSRO
TESARO, Inc.
TSRO
$7.69M
5
NBIX icon
Neurocrine Biosciences
NBIX
$7.58M

Top Sells

1
INCY icon
Incyte
INCY
$43.4M
2
BLUE
bluebird bio
BLUE
$15.7M
3
ALXN
Alexion Pharmaceuticals Inc
ALXN
$12.1M
4
CELG
Celgene Corp
CELG
$11.6M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
$10.3M

Sector Composition

1 Consumer Staples 52.04%
2 Healthcare 33.12%
3 Consumer Discretionary 12.51%
4 Financials 0.85%
5 Industrials 0.32%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
NTLA icon
51
Intellia Therapeutics
NTLA
$1.26B
$3.52M 0.08%
250,000
– –
IMUX icon
52
Immunic
IMUX
$79.4M
$3.5M 0.08%
+21,875
New +$3.5M
CMRX
53
DELISTED
Chimerix, Inc.
CMRX
$3.19M 0.07%
500,000
– –
RGNX icon
54
Regenxbio
RGNX
$498M
$3.09M 0.07%
160,000
– –
NVLN
55
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$2.75M 0.06%
256,400
– –
SNDX icon
56
Syndax Pharmaceuticals
SNDX
$1.39B
$2.74M 0.06%
+200,000
New +$2.74M
LOXO
57
DELISTED
Loxo Oncology, Inc
LOXO
$2.74M 0.06%
65,000
-35,000
-35% -$1.47M
ONCE
58
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.67M 0.06%
50,000
– –
CLDX icon
59
Celldex Therapeutics
CLDX
$1.57B
$2.44M 0.05%
45,000
– –
NERV icon
60
Minerva Neurosciences
NERV
$16.8M
$2.04M 0.05%
31,413
– –
RARE icon
61
Ultragenyx Pharmaceutical
RARE
$3.04B
$2.03M 0.05%
30,000
-20,000
-40% -$1.36M
PRQR icon
62
ProQR Therapeutics
PRQR
$256M
$2M 0.04%
+400,000
New +$2M
ADAP
63
Adaptimmune Therapeutics
ADAP
$13.9M
$1.65M 0.04%
300,000
– –
AKAO
64
DELISTED
Achaogen, Inc.
AKAO
$1.51M 0.03%
60,000
– –
ANAB icon
65
AnaptysBio
ANAB
$630M
$1.24M 0.03%
+44,690
New +$1.24M
KDNY
66
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$1.08M 0.02%
20,000
– –
IMDX
67
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$73.3M
$893K 0.02%
7,500
+4,295
+134% +$511K
STML
68
DELISTED
Stemline Therapeutics, Inc.
STML
$855K 0.02%
+100,000
New +$855K
IBRX icon
69
ImmunityBio
IBRX
$2.24B
$799K 0.02%
225,000
– –
NDRM
70
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
$664K 0.01%
+25,000
New +$664K
NVAX icon
71
Novavax
NVAX
$1.2B
$640K 0.01%
25,000
– –
XENE icon
72
Xenon Pharmaceuticals
XENE
$2.99B
$600K 0.01%
+150,000
New +$600K
DMTX
73
DELISTED
Dimension Therapeutics, Inc
DMTX
$410K 0.01%
234,493
– –
CELG
74
DELISTED
Celgene Corp
CELG
– –
-100,000
Closed -$11.6M
CLCD
75
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
– –
-5,575
Closed -$203K
1 2
3
4